The emergence of GLP-1 receptor agonists like semaglutide and tirzepatide has transformed the approach to addressing type 2 diabetes and supporting weight reduction. While both drugs share a common mechanism of action https://mathertcc958961.wikiannouncement.com/9930391/semaglutide_tirzepatide_semaglutide_vs_tirzepatide_comparing_semaglutide_and_tirzepatide